Marfan Syndrome Diagnosis and Management

Diagnostic Criteria

• The American College of Medical Genetics and Genomics recommends calculating the systemic score using specific criteria, including dural ectasia = 2 points 1
• Scoliosis or thoracolumbar kyphosis is assigned 1 point in the systemic score 2
• Facial features, including dolichocephaly, enophthalmos, downslanting palpebral fissures, malar hypoplasia, and retrognathia, are assigned 1 point if 3 of 5 features are present 3
• Skin striae are assigned 1 point in the systemic score 4
• Myopia > 3 diopters is assigned 1 point in the systemic score 3
• Mitral valve prolapse is assigned 1 point in the systemic score 5

Clinical Features

• The combination of pectus excavatum, scoliosis, and low muscle mass represents classic skeletal involvement in Marfan syndrome, occurring due to defective fibrillin-1 protein affecting connective tissue integrity 1, 3, 4
• Joint hypermobility rather than true inflammation is a common feature of Marfan syndrome and related connective tissue disorders 1, 3, 6
• Weakness, fatigue, and low muscle mass reflect the muscular hypoplasia and adipose hypoplasia characteristic of Marfan syndrome 1

Cardiovascular Concerns

• Fainting episodes may indicate mitral valve prolapse with arrhythmias 1, 4
• Fainting episodes may indicate aortic root complications 6, 7
• Fainting episodes may indicate autonomic dysfunction 8

Differential Diagnosis

• Loeys-Dietz Syndrome must be excluded as it carries a higher risk of aortic dissection even without significant dilation 6, 7, 5

Family History Assessment

• Personally examine parents and siblings for features including scoliosis, striae atrophicae, disproportionate stature, MVP, and aortic root dilation, as these are often clinically silent 3, 6, 4

Common Pitfalls to Avoid

• Do not dismiss Marfan syndrome as isolated familial pectus excavatum or benign joint hypermobility without comprehensive cardiovascular evaluation 1, 3, 4
• Do not delay echocardiography even if the patient appears otherwise healthy 6, 7, 5
• Do not assume normal vision excludes Marfan syndrome - ectopia lentis requires specialized ophthalmologic examination and may be subtle 6, 7, 5

Marfan Syndrome Diagnosis and Management

Diagnostic Criteria

• The American College of Medical Genetics and Genomics recommends that a diagnosis of Marfan syndrome be made when a patient has aortic root dilation (Z-score ≥ +2) plus ectopia lentis 9
• A diagnosis can also be made when a patient has aortic root dilation plus a pathogenic FBN1 mutation, as recommended by the American College of Medical Genetics and Genomics 10
• The American College of Medical Genetics and Genomics also recommends that a diagnosis can be made when a patient has aortic root dilation plus a systemic score ≥7 points 11
• Ectopia lentis plus an FBN1 mutation previously associated with aortic disease is also a diagnostic criterion, as recommended by the American College of Medical Genetics and Genomics 9

Systemic Features Scoring System

• The American College of Medical Genetics and Genomics recommends a systemic features scoring system, where wrist AND thumb sign = 3 points, pectus carinatum = 2 points, hindfoot deformity = 2 points, pneumothorax = 2 points, dural ectasia = 2 points, and protrusio acetabuli = 2 points 9, 12, 11
• A score of ≥7 points constitutes "multiple systemic features" for diagnostic purposes, as recommended by the American College of Medical Genetics and Genomics 9, 12, 11

Management Strategy

• The American Heart Association recommends annual echocardiography for patients with aortic root diameter <4.5 cm in adults AND growth rate <0.5 cm/year 9, 12, 10
• The American Heart Association also recommends echocardiography every 6 months when diameter >4.5 cm OR growth rate >0.5 cm/year 12, 11
• Complete aortic imaging (MRA or CT) starting in young adulthood is recommended by the American Heart Association 12, 11
• Prophylactic aortic root repair is indicated when aortic root diameter >4.5 cm, growth rate >1 cm/year, progressive aortic regurgitation, or aortic root diameter >5.0 cm with aortic root-to-height ratio >10, as recommended by the American Heart Association 12, 11, 13
• β-blocker therapy is indicated for all patients with aortic root dilation or meeting diagnostic criteria for Marfan syndrome, as recommended by the American College of Medical Genetics and Genomics 9, 12, 11

Positive Wrist Sign – Diagnostic Weight and Clinical Work‑up for Marfan Syndrome

1. Diagnostic Scoring of the Wrist Sign

• The positive wrist (Walker‑Murdoch) sign contributes 1–3 points toward the systemic score in the revised Ghent criteria for Marfan syndrome. 14
• Wrist sign alone adds 1 point to the systemic features score. 14
• Wrist sign + thumb sign together add 3 points to the systemic score. 14, 15

2. Cardiovascular Evaluation (Urgent)

• Aortic root dilation is defined as a Z‑score ≥ +2 standard deviations above the mean for age, sex, and body‑surface area. 14, 16
• Measurement of the ascending aorta (including Z‑score calculation) should be performed on transthoracic echocardiography, with values adjusted for age, sex, and body‑surface area. 16

3. High‑Value Systemic Features (Points for the Ghent Score)

4. Genetic Testing

• FBN1 mutation analysis detects pathogenic variants in 90–95 % of individuals with Marfan syndrome. 16

5. Diagnostic Criteria (No Family History)

• Aortic root dilation (Z ≥ +2) + ectopia lentis establishes the diagnosis. 16
• Aortic root dilation + pathogenic FBN1 mutation establishes the diagnosis. 15
• Aortic root dilation + systemic score ≥ 7 points establishes the diagnosis. 16
• Ectopia lentis + FBN1 mutation previously linked to aortic disease establishes the diagnosis. 15

6. Diagnostic Criteria (Positive Family History)

• Ectopia lentis alone is sufficient for diagnosis. 14, 17
• Systemic score ≥ 7 points is sufficient for diagnosis. 14
• Aortic root dilation defined as Z > +2 if age > 20 years or Z > +3 if age < 20 years is sufficient for diagnosis. 16

7. Management Recommendations

• β‑blocker therapy is recommended for all patients who have aortic root dilation or meet diagnostic criteria for Marfan syndrome. 15
• Surgical repair of the aortic root is indicated when the diameter exceeds 4.5 cm, the growth rate exceeds 1 cm / year, or there is progressive aortic regurgitation. 15

8. Comparative Note – Hypermobile Ehlers‑Danlos Syndrome

• Aortic root dilation occurs in 25–33 % of patients with hypermobile Ehlers‑Danlos syndrome, although the risk of dissection without marked dilation is low. 14